These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. The use of classic psychedelics among adults: a Danish online survey study. Søgaard Juul T; Ebbesen Jensen M; Fink-Jensen A Nord J Psychiatry; 2023 May; 77(4):367-378. PubMed ID: 36173202 [TBL] [Abstract][Full Text] [Related]
46. Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants. Galvão-Coelho NL; Marx W; Gonzalez M; Sinclair J; de Manincor M; Perkins D; Sarris J Psychopharmacology (Berl); 2021 Feb; 238(2):341-354. PubMed ID: 33427944 [TBL] [Abstract][Full Text] [Related]
47. Microdosing psychedelics: Motivations, subjective effects and harm reduction. Lea T; Amada N; Jungaberle H; Schecke H; Klein M Int J Drug Policy; 2020 Jan; 75():102600. PubMed ID: 31778967 [TBL] [Abstract][Full Text] [Related]
48. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer. Barnett BS; Greer GR J Acad Consult Liaison Psychiatry; 2021; 62(4):460-471. PubMed ID: 34210406 [TBL] [Abstract][Full Text] [Related]
49. The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits. Videira NB; Nair V; Paquet V; Calhoun D J Appl Toxicol; 2024 Feb; 44(2):216-234. PubMed ID: 37646119 [TBL] [Abstract][Full Text] [Related]
50. Dosing Psychedelics and MDMA. Liechti ME; Holze F Curr Top Behav Neurosci; 2022; 56():3-21. PubMed ID: 34734392 [TBL] [Abstract][Full Text] [Related]
51. Psychedelics for Patients With Cancer: A Comprehensive Literature Review. White CM; Weisman N; Dalo J Ann Pharmacother; 2023 Sep; 57(9):1062-1075. PubMed ID: 36635883 [TBL] [Abstract][Full Text] [Related]
52. Do randomized clinical trials with inadequate blinding report enhanced placebo effects for intervention groups and nocebo effects for placebo groups? Feys F; Bekkering GE; Singh K; Devroey D Syst Rev; 2014 Feb; 3():14. PubMed ID: 24555576 [TBL] [Abstract][Full Text] [Related]
53. Analysis of recreational psychedelic substance use experiences classified by substance. Hase A; Erdmann M; Limbach V; Hasler G Psychopharmacology (Berl); 2022 Feb; 239(2):643-659. PubMed ID: 35031816 [TBL] [Abstract][Full Text] [Related]
54. A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder. Velit-Salazar MR; Shiroma PR; Cherian E Brain Sci; 2024 Mar; 14(3):. PubMed ID: 38539636 [TBL] [Abstract][Full Text] [Related]
55. Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies. Calleja-Conde J; Morales-García JA; Echeverry-Alzate V; Bühler KM; Giné E; López-Moreno JA Addict Biol; 2022 Nov; 27(6):e13229. PubMed ID: 36301215 [TBL] [Abstract][Full Text] [Related]
56. Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm. Perkins D; Sarris J; Rossell S; Bonomo Y; Forbes D; Davey C; Hoyer D; Loo C; Murray G; Hood S; Schubert V; Galvão-Coelho NL; O'Donnell M; Carter O; Liknaitzky P; Williams M; Siskind D; Penington D; Berk M; Castle D Aust N Z J Psychiatry; 2021 Dec; 55(12):1127-1133. PubMed ID: 33745287 [TBL] [Abstract][Full Text] [Related]
57. Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives. Kaypak AC; Raz A Transcult Psychiatry; 2022 Oct; 59(5):665-674. PubMed ID: 36031848 [TBL] [Abstract][Full Text] [Related]
59. Altered States and Social Bonds: Effects of MDMA and Serotonergic Psychedelics on Social Behavior as a Mechanism Underlying Substance-Assisted Therapy. Schmid Y; Bershad AK Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 May; 9(5):490-499. PubMed ID: 38341085 [TBL] [Abstract][Full Text] [Related]
60. Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT. Griffiths RR; Hurwitz ES; Davis AK; Johnson MW; Jesse R PLoS One; 2019; 14(4):e0214377. PubMed ID: 31013281 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]